🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06858553
Recruiting Observational

AI-Assisted MRE for Intestinal Fibrosis in Crohn's Disease

NCT06858553 · tracked via the Priya Life Science China tracker
Sponsor
Minhu Chen
Phase
Observational
Started
2025-06-03
Last updated
2025-08-05

Condition(s) studied

Crohn Disease (CD)

Study summary

Intestinal fibrotic strictures represent a severe complication of Crohn's disease (CD), affecting over half of the patients. Despite the continuous emergence of novel medications, effective treatment options remain scarce. Endoscopy fails to identify the full-thickness fibrosis of the bowel wall, and standardized assessment for cross-sectional imaging has yet to be established. Previous studies have demonstrated that radiomics models based on computed tomography and deep learning models exhibit commendable diagnostic capability. Thus, this project seeks to conduct a prospective multicenter study, with plans to recruit 234 CD patients requiring bowel resection from five medical centers. The aim is to develop and validate a deep learning model based on magnetic resonance enterography (MRE) to accurately characterize intestinal fibrosis.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Patients Over 18 years old with a confirmed diagnosis of CD based on the criteria of ECCO guideline. 2. Planning to receive a bowel resection due to stricture in ileum or colon, and availability of histological specimens of resected intestinal walls matched with MRE are expected to be available. 3. Clear boundaries of the target bowel tract enable accurate semi-automatic or fully automatic intestinal segmentation Exclusion Criteria: 1. Cannot undergo MRI examination 2. Difficult to obtain suitable tissue after surgery 3. MRE imaging is of poor quality or contains artifacts 4. The target bowel is located at the anastomosis (ie, anastomotic stricture) 5. Intestinal lesions concurrent with other diseases

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
The First Affiliated Hospital,Sun Yat-sen University Guangzhou Guangdong Recruiting
Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou Guangdong Not Yet Recruiting
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University Nanjing Jiangsu Not Yet Recruiting
Ruijin Hospital, Shanghai Jiaotong University School of Medicine Huangpu Shanghai Municipality Not Yet Recruiting
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06858553 on ClinicalTrials.gov ↗ ← All trials in China